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ABSTRACT 
 
The present study examined inter-rater agreement on the Anxiety Disorder 
Interview Schedule DSM-IV Child and Parent Interview (ADIS-IV-C/P) in youth with 
autism spectrum disorder and if age and ASD diagnosis moderated agreement. Diagnoses 
established for 70 7-16-year-old youth with ASD during a live administration of the 
ADIS-IV-C/P were compared to diagnoses identified by a second rater after listening to 
audiotaped recordings of the interviews. Inter-rater agreement on parent and child reports 
was excellent (k=1.00). Inter-rater agreement on principal diagnoses (k=0.91), individual 
anxiety diagnoses (k=0.85-0.97), and other comorbid diagnoses (i.e., major depressive 
disorder, dysthymia, oppositional defiant disorder, attention deficit hyperactivity 
disorder-Inattention/Hyperactivity/Combined Type) (0.89-1.00) were excellent; 
agreement did not differ as a function of ASD diagnosis or age. Results suggest that the 
anxiety disorders and comorbid disorders assessed by the ADIS-IV-C/P can be diagnosed 
by pairs of clinicians with good reliability. 
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INTRODUCTION 
Autism spectrum disorders (ASD), which are comprised of the diagnoses Autistic 
Disorder, Asperger’s Syndrome, and Pervasive Developmental Disorder-Not Otherwise 
Specified (PDD-NOS), are characterized by social and/or communication deficits and/or 
restrictive/repetitive behaviors (American Psychiatric Association, 2000). Individuals 
diagnosed with Autistic Disorder display qualitative impairments in social and 
communication skills and restrictive/repetitive behaviors prior to the age of 3 years. Their 
symptoms are not accounted for by Rett’s Disorder or Childhood Disintegrative Disorder. 
Individuals diagnosed with Asperger’s Syndrome display qualitative impairments in 
social interaction skills and restrictive/repetitive behaviors, and they have no significant 
delay in language and cognitive development. Individuals diagnosed with PDD-NOS 
display severe and pervasive impairment in the development of reciprocal social 
interaction, communication skills or restrictive/repetitive behaviors, and they do not meet 
the criteria for Autistic Disorder because of late age of onset, atypical symptomology, 
and/or sub-threshold symptomology (American Psychiatric Association, 2000). 
Qualitative impairment in social interaction and communication skills include 
behaviors such as a lack of joint attention and emotional reciprocity, difficulty in 
understanding social cues, inability to share enjoyment with others, a reluctance or 
difficulty initiating or maintaining social interactions, a delay or lack of development of 
speech without any compensatory gesture, a failure to respond to others’ speech (e.g., 
does not orient to his/her own name), stereotyped and repetitive use of language, pronoun 
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reversal (e.g., referring to others as “I” and to themselves as “You”), and a failure to 
initiate or sustain conversation normally (American Psychiatric Association, 2000). 
Restrictive/repetitive behaviors may include excessive and intensive preoccupation with 
certain interests, inflexible adherence to rules and structure, and stereotyped or repetitive 
motor movements such as hand-flapping or complex body movements which can be 
displayed for hours or only briefly (DSM-IV-TR, 2000). Currently, ASD affects as many 
as 1 in 88 youth in the United States with  higher incidence in boys (1 in 58 boys) (Center 
for Disease Control and Prevention, 2012; Fombonne, 2005). 
Between 30 and 80% of children and adolescents with ASD also have clinically 
significant anxiety (de Bruin, Ferdinand, Meester, de Nijs, & Verheij, 2007; Gillot, 
Furniss, & Walter, 2001; Leyfer et al., 2006; Muris, Steerneman, Merckelbach, 
Holdrinet, & Meesters, 1998; Sukhodolsky et al., 2008; van Steensel, Bogels, & Perrin, 
2011; see White, Oswald, Ollendick, & Scahill, 2009, for a review). Anxiety disorders 
are more prevalent in youth with ASD than in typically developing children and youth 
with ASD have similar or higher levels of anxiety than do clinically anxious samples 
(e.g., Bellini, 2004; Farrugia & Hudson, 2006; Giliot, Furniss, & Walter, 2001; Weisbrot, 
Gadow, DeVincent, & Pomeroy, 2005). Common comorbid anxiety disorders reported in 
children and adolescents with ASD include obsessive-compulsive disorder (OCD; 17-
37%), separation anxiety disorder (SAD; 9-38%), specific phobia (26-57%), social 
phobia (13-40%), panic disorder (2-25%), and generalized anxiety disorder (GAD; 15-
35%) (Leyfer et al., 2006; Simonoff et al., 2008; van Steensel et al., 2011; see White et 
al., 2009, for a review). 
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Specific phobia, panic disorder, SAD, and GAD are more likely to be diagnosed 
in youth with PDD-NOS than in youth with Autistic Disorder or Asperger’s Syndrome 
(Muris et al., 1998; van Steensel et al., 2011). Obsessive-compulsive disorder and 
specific phobia are more likely to be diagnosed in youth with Autistic Disorder than in 
youth with Asperger’s Syndrome. Youth with Asperger’s Syndrome often report the 
highest levels of anxiety when compared to youth with PDD-NOS and Autistic Disorder 
diagnosis, reflecting varying levels of anxiety across diagnoses (Weisbrot et al., 2005). 
This may be reflective of greater insight in youth with Asperger’s Syndrome that enables 
them to communicate their anxiety and be more cognizant of their impairments than 
youth who have less insight (Gillott et al., 2001; Kim et al., 2000; Sukholdosky et al., 
2008). 
Youth with ASD and clinical anxiety disorders experience significant impairment 
in school, home, and family functioning (Chamberlain et al., 2007). Specific domains of 
impairment that may be further exacerbated by the presence of clinical anxiety symptoms 
include functioning in school/academic domains, home life, and social relationships 
(Bellini, 2004; Kim et al., 2000; Muris et al., 1998; Sukhodolsky et al., 2008; Wood & 
Gaddow, 2010). Anxiety symptoms can compound functional impairments such as life 
skills, ability to work, and ability to be independent. As a result, youth with ASD may be 
at increased risk for peer rejection, depression, and loneliness (Attwood, 2003; 
Bauminger & Kasari, 2000; Kim et al., 2000; Storch, Masia-Warner, & Brassard, 2003; 
Tantam, 2003); however, information regarding long term outcomes related to anxiety in 
youth with ASD and typically developing youth is unknown. Consequently, early 
identification of clinical anxiety symptoms is crucial in this population. 
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 When assessing clinical levels of anxiety in youth with ASD, clinicians often are 
faced with the difficulties of separating subclinical anxiety symptoms from ASD 
symptoms given substantial symptom overlap, lack of clarity in differential diagnosis, 
poor agreement among informants, lack of child insight, difficulty of the parent reporting 
on child internal states, cognitive and language limitations of the child, and limitations of 
existing constructed clinical interviews (Campbell & Rapee, 1996; MacNeil, Lopes, & 
Minnes, 2009; Storch et al., 2013; van Steensel et al., 2011; see White et al., 2009, for a 
review; Wood & Gaddow, 2010). 
Despite the known difficulties associated with diagnosing anxiety disorders in 
youth with ASD (e.g., separating subclinical anxiety symptoms from ASD symptoms 
given symptom overlap, lack of clarity in differential diagnosis, poor agreement among 
informants, lack of child insight, difficulty of the parent reporting on child internal states, 
cognitive and language limitations of the child) (van Steensel et al., 2011; White et al., 
2009; Wood & Gaddow, 2010), few empirical studies have explored the psychometric 
properties of anxiety assessments in this population (see Nadeau et al., 2011). In 
particular, the Anxiety Disorder Interview Schedule DSM-IV Parent and Child Interview 
(ADIS-IV-C/P; Silverman & Albano, 1996), which is a structured diagnostic measure 
with complementary parent and child interviews, has received little attention regarding its 
psychometric properties despite its frequent use in typically developing children and 
increasing use in youth with ASD (e.g., Reaven, Blakeley-Smith, Culhane-Shelburne, & 
Hepburn, 2011; Storch et al., 2013; Wood et al., 2009).  Among typically developing 
children and adolescents, the ADIS-IV-C/P has generally demonstrated strong reliable 
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properties across time (Silverman et al., 2001) and poor to strong agreement among 
informants (Choudhury et al., 2003; Grills & Ollendick, 2003). 
 To date, four studies investigated inter-rater agreement of the ADIS-III-C/P and 
ADIS-IV-C/P (Lyneham, Abbott, & Rapee, 2007; Lyneham & Rapee, 2005; Rapee, 
Barrett, Dadds, & Evans, 1994; Silverman & Nelles, 1988). Lyneham and colleagues 
(2007) examined the inter-rater agreement of the ADIS-IV-C/P by comparing clinician 
ratings of 153 typically developing youth aged 7 to 16 years performed face-to-face with 
parents and their children, and clinician ratings performed after viewing a videotape of 
the assessment. Inter-rater agreement on principal diagnosis ranged from good to 
excellent (kappa [k] ranging from .80-1.0), individual anxiety disorders (k ranging from 
.80-1.0), and comorbid disorders (k ranging from .65-.77). Agreement for principal 
diagnosis and all anxiety disorders based solely on child information or solely on parent 
information ranged from good to excellent (k ranging from .72-.94 and k ranging from 
.78-.95, respectively). However, patterns of disagreement were noticed when clinicians 
tried to determine if GAD or social phobia was the principal diagnosis, which may reflect 
limitations of the ADIS-IV-C/P in separating GAD symptoms from those of social 
phobia. 
 Lyneham and Rapee (2005) examined the inter-rater agreement of the ADIS-IV-
C/P by comparing clinician ratings of 73 typically developing youth aged 6 to 12 years 
performed face-to-face with parents and their children, and clinician ratings performed 
over the telephone. Inter-rater agreement was good to excellent for principal diagnosis (k 
= .86), individual anxiety disorders (k ranging from .63-.86), and other disorders (k 
ranging from .79-.91). Researchers concluded that telephone administration of the ADIS-
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IV-C/P was as reliable and valid as face-to-face administrations for determining the 
presence or non-presence of anxiety disorders in children, which suggests that formats 
other than face-to-face administration of the ADIS-IV-C/P may be reliable. 
Rapee and colleagues (1994) examined the inter-rater agreement for the anxiety 
disorders in the ADIS-III-R-C/P by comparing clinician ratings of 161 typically 
developing youth aged 7 to 14 years performed face-to-face with parents and their 
children and clinician ratings obtained after viewing videotaped parent and child sessions. 
Inter-rater agreement on principal and additional diagnoses was fair to excellent (k 
ranging from .59 to .82). Inter-rater agreement also appeared to be higher for older 
children. Silverman & Nelles (1988) examined the inter-rater agreement for the anxiety 
and comorbid disorders in the ADIS-III-R-C/P by comparing clinician ratings of 51 
typically developing youth. Inter-rater agreement on principal diagnosis and secondary 
diagnoses was moderate to high. 
Moderators of Inter-rater Agreement 
Some data suggest that certain variables moderate clinician inter-rater reliability 
and parent-child agreement on clinical anxiety diagnoses such as child’s age (see 
Lyneham et al., 2007; Rapee et al., 1994; Storch et al., 2012a) and ASD diagnosis (see 
Muris et al., 1998; van Steensel et al., 2011). If these two variables are found to be 
significant moderators of inter-rater agreement, they may help to explain the varying 
degrees of agreement or disagreement among raters. For example, if inter-rater agreement 
is better for older children, this may suggest that older children are more aware of their 
symptoms and are better reporters of their symptoms than younger children. These 
findings may inform raters to continue to question the reliability of young children’s 
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responses. Similarly, if ASD diagnosis is found to be a significant moderator of inter-
rater agreement, raters may want to take extra precautions in making sure their ratings are 
reliable or be wary of their conclusions when they are interviewing youth with a certain 
ASD diagnosis. 
Age of Child. In a meta-analysis performed on anxiety disorders in youth with 
ASD, van Steensel and colleagues (2011) identified 31 studies involving 2,121 youth 
(age < 18 years) with ASD. Results revealed that anxiety disorders were more likely to be 
diagnosed in older children than in younger children. Older youth with ASD were more 
likely to report anxiety symptoms, suggesting that rates of anxiety disorders may increase 
with age or that youth are better able to report their anxiety symptoms as they age. These 
results have been supported by several other studies using a variety of anxiety measures 
in typically developing children (DISC; Edelbrock et al., 1985; ADIS-III-C/P; Silverman 
& Eisen, 1992; Rapee et al., 1994), although some studies have found no significant 
moderating effect of age on inter-rater agreement (see Lyneham et al., 2007; Rapee et al., 
1994). 
Autism Spectrum Disorders Diagnoses. Autism spectrum disorders diagnoses 
are hypothesized to moderate agreement because of varying levels of deficits in 
communication (Buitelaar et al., 1999; Cohen et al., 1986; Prior et al., 1998; Sevin et al., 
1995; Walker et al., 2004), abstract reasoning (de Bruin et al., 2006; Prior et al., 1998; 
Walker et al., 2004), and insight across ASD diagnoses such that lower functioning youth 
with ASD or youth with more severe ASD symptoms may have poorer insight into their 
anxiety symptoms than higher functioning youth with ASD (Gillott et al., 2001; Kim et 
al., 2000; Sukholdosky et al., 2008) and the presence of comorbid disorders across ASD 
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diagnoses (Muris et al., 1998; van Steensel et al., 2011) can affect the ability of the 
clinician to accurately diagnose the presence of anxiety disorder(s) and agree upon a 
diagnosis. A youth with ASD who has difficulties reporting his or her anxiety symptoms 
and associated impairments or confuses ASD symptoms for anxiety symptoms will make 
it more difficult for a clinician to accurately diagnose an anxiety disorder. This can 
greatly affect inter-rater agreement. Furthermore, the presence of comorbid disorders can 
obscure anxiety symptoms, hinder anxiety assessments, and, overall, make it more 
difficult for a clinician to retrieve relevant information. For example, a youth with ASD 
who also has attention difficulties might struggle to pay attention to and answer the 
questions being asked and may need questions to be repeatedly clarified. As a result, a 
clinician may question the integrity of the answers and the diagnoses made from these 
reports. 
To date, no study has investigated the inter-rater reliability of the ADIS-IV-C/P in 
children and adolescents with ASD despite its increasingly frequent use in youth with 
ASD (e.g., Storch et al., 2013; Wood et al., 2009). Investigating the reliability of a 
measure is essential because 1) reliable diagnoses lead to better treatment specificity, 2) 
in order for a measure to be valid, it must be reliable, and 3) it allows us to explore the 
extent to which bias and other relevant factors may impact raters’ abilities to reach an 
objective diagnoses. Furthermore, researchers are increasingly studying anxiety and ASD 
and they must be able to reliably assess anxiety in youth with ASD to enroll appropriate 
participants for their studies. In light of the few studies that have examined the inter-rater 
agreement of the ADIS-IV-C/P, and the importance of reliable diagnoses, this study had 
the following aims: 1) examine the inter-rater agreement on the ADIS-IV-C/P with 
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respect to principal diagnosis, individual anxiety disorders, and comorbid DSM-IV 
disorders as endorsed by the child and parent, and a clinician diagnosis and 2) determine 
whether clinician inter-rater agreement on clinician diagnoses is moderated by child’s age 
and ASD diagnosis. 
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METHOD 
Participants  
Participants were comprised of 70 parents and their children (ages 7-16 years) 
who have an autism spectrum disorder diagnosis, confirmed through the administration of 
the Autism Diagnostic Observation Schedule (ADOS; Lord, Rutter, DiLavore, & Risi, 
2000) and Autism Diagnostic Interview-Revised (ADI-R; Rutter et al., 2003), and have 
completed an audio recorded or videotaped ADIS-IV-C/P at the screening visit. 
Participants were recruited for one of four studies examining the efficacy of cognitive 
behavioral therapy for anxiety in youth with ASD. These four studies have similar 
inclusion/exclusion criteria and study design. Inclusion and exclusion criteria of all four 
studies are presented in Table 1. 
Measures 
 Anxiety Disorders Interview Schedule for DSM-IV– Child and Parent 
Version (ADIS-IV-C/P). The ADIS-IV-C/P (Silverman & Albano, 1996) is a clinician-
administered, structured interview used to assess the presence, severity and level of 
interference of anxiety disorders and common disorders in youths based upon the criteria 
set by the DSM-IV-TR (APA, 2000). Parent and child are interviewed separately and a 
list of diagnoses endorsed by the parent and child are recorded. Clinician diagnosis is 
determined by the clinician after considering the disorders endorsed by parent and child. 
Clinical diagnoses reflect endorsement of symptoms and a severity rating (patient 
impairment/distress) of at least 4 on a 0-8 scale. Principal diagnoses represent the most 
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distressing/interfering anxiety disorder. The ADIS-IV-C/P has demonstrated strong 
psychometric properties in typically developing youth, including test-retest reliability 
(Silverman, Saavedra, & Pina, 2001), inter-rater reliability (Silverman & Albano, 1996), 
and concurrent validity (Wood, Piacentini, Bergman, McCracken, & Barrios, 2002). 
Autism Diagnostic Interview- Revised (ADI-R). The ADI-R (Rutter et al., 
2003) is a standardized semi-structured clinical diagnostic interview for assessing ASD in 
children and adults based on the diagnostic criteria for autism in the DSM-IV-TR (APA, 
2000). Caregivers are asked questions concerning their child’s behavior through a 
structured interview with a clinician. The ADI-R focuses on behaviors in the three 
content areas or domains often displayed by children and adults with ASD: quality of 
social interaction (e.g., emotional sharing, offering and seeking comfort, social smiling 
and responding to peers); communication and language (e.g., stereotyped utterances, 
pronoun reversal, social usage of language); and repetitive, restricted and stereotyped 
interests and behavior (e.g., unusual preoccupations, hand and finger mannerisms, 
unusual sensory interests) (Rutter et al., 2003). All questions ask about current behavior, 
with the exception of a few behaviors that only occur during specific age periods. The 
ADI-R has demonstrated strong psychometric properties, including test-retest reliability, 
inter-rater reliability, and discriminant validity (Lord, Rutter, & Le Couteur, 1994). In the 
child and adolescent studies, the ADI-R was administered at the screen visit. 
Autism Diagnostic Observation Schedule (ADOS)-Module 3. The ADOS–
Module 3 is a structured observation assessment used to elicit atypical language use, 
social interaction, and stereotyped behaviors of individuals suspected of having ASD 
(Lord, Rutter, DiLavore, & Risi, 2000). The ADOS has demonstrated strong 
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psychometric properties, including test-retest reliability, inter-rater reliability, and 
discriminant validity (Lord et al., 1999; Lord et al., 2000). 
Clinicians 
Original raters who had audio-recorded their ADIS-IV-C/P were research 
assistants who were trained to reliably administer the ADIS-IV-C/P. Parent and child 
interviews were conducted by the same clinician. A second rater who was blind to the age 
and ASD diagnosis of the child and was trained to administer the ADIS-IV-C/P was used 
to establish inter-rater agreement. This rater had observed and rated multiple ADIS-IV-
C/P under the supervision of a qualified and reliable rater of that ADIS-IV-C/P and had 
achieved an inter-rater agreement of 80% or above on all ADIS-IV-C/P observed. 
Procedure 
Following a telephone screening in which basic inclusion/exclusion criteria were 
assessed, families were invited for an in-person visit. At this visit, a written parent 
consent and child assent was obtained and the parents and their child were administered a 
series of measures by trained clinicians including the ADIS-IV-C/P at the screening visit. 
In all clinical studies, parents consented and children assented to the audio recordings of 
measures and for their use in research. ADIS-IV-C/P interviews were conducted with the 
child and parent separately. After completing the interview, the rater assigned diagnoses 
based upon parent and child interviews. The second rater listened to the audiotapes of 
previous ADIS-IV-C/P taken at the screen visit and scored the ADIS-IV-C/P based upon 
these recordings. The order that the parent and child recordings were rated was 
randomized. Parent, child and clinician diagnoses were compared to assess inter-rater 
agreement. All studies were approved by the local institutional review board. 
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Data Analysis 
Cohen’s Kappa (Cohen, 1960) was calculated for each individual anxiety and 
comorbid diagnosis A 2x2 Cohen Kappa table was used to calculate a kappa coefficient 
for each individual anxiety and comorbid diagnosis. See Figure 1. A 4 x4 Cohen Kappa 
table was used to calculate a kappa coefficient for principal diagnosis. Per inclusion 
criteria, generalized anxiety disorder, social phobia, separation anxiety disorder, and 
obsessive-compulsive disorder were the anxiety disorders that could be chosen to 
represent principal diagnosis. The 95% confidence intervals for Cohen’s Kappas were 
calculated using the following equation: k-1.96×standard error (k) to k+1.96×standard 
error (k) (Blackman & Koval, 2000).The following guidelines set by Mannuzza et al. 
(1989) were used to interpret kappa values: kappa values less than 0.40 are considered 
poor agreement, kappa values 0.40-0.60 are considered fair agreement, kappa values 
0.60-0.74 are considered good agreement, and kappa values greater than 0.74 are 
considered excellent agreement. 
Participants were split into two groups, the child group (aged 7-11, n=41) and 
adolescent group (aged 12-16 years, n=29) to investigate whether age was a moderator of 
inter-rater agreement. Participants were split into three groups, youth with Autistic 
Disorder, youth with Asperger’s Syndrome, and youth with PDD-NOS to investigate 
whether ASD diagnosis was a moderator of inter-rater agreement. Overlaps in kappa 
confidence intervals were examined to determine moderator effects.  
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RESULTS 
Sample 
Of the 70 participants, consisting mainly of male participants (n=51), 23 
participants were diagnosed with Autistic Disorder, 32 participants were diagnosed with 
Asperger’s Syndrome, and 15 participants were diagnosed with PDD-NOS. The mean 
age of the sample was 11 years (SD=2.26 years). Demographics and diagnostic 
characteristics are presented in Table 2.  Demographic characteristics were not 
statistically different across ASD child studies and ASD adolescent studies from which 
the participants were recruited. See Table 3. 
Principal Diagnosis 
The kappa coefficient for inter-rater agreement on principal diagnosis was 0.91 
which signified excellent agreement.  
Anxiety Disorders/Comorbid DSM-IV Diagnoses 
Kappa coefficients for inter-rater agreement on parent and child ratings for 
individual anxiety disorders and comorbid disorders were 1.00, which signified perfect 
agreement. No disagreements were found in clinician-to-clinician ratings of parent and 
child ratings. Inter-rater agreement on individual anxiety disorders was excellent (k= 
0.85-1.00). Inter-rater agreement on mood disorders and externalizing disorders was 
excellent (k= 0.89-1.00). Kappa coefficients for individual anxiety disorders and other 
comorbid DSM-IV diagnoses are presented in Table 4. 
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Moderators of Inter-rater Agreement 
Age. Age was not a significant moderator of inter-rater agreement. However, 
inter-rater agreement among the adolescent group varied more so than the child group, 
ranging from good to excellent agreement (k= 0.73-1.00) for the adolescent group versus 
excellent agreement for the child group (k= 0.90-1.00). In the adolescent group, good 
agreement was found on SAD (k= 0.73) while all other anxiety disorders and comorbid 
DSM-IV diagnoses had excellent agreement (k= 0.83-1.00). Excellent agreement was 
found across age group on principal diagnosis (child group: k= 0.88, adolescent group: 
k= 0.94). See Table 5 for inter-rater agreement on individual diagnoses using age as a 
moderator. 
ASD Diagnosis. ASD diagnosis was not a significant moderator of inter-rater 
agreement. Excellent agreement on individual anxiety diagnoses and comorbid DSM-IV 
diagnoses was found within each ASD diagnosis with the exception of good agreement 
for SAD in the youth with PDD-NOS. Kappa coefficients in Autistic Disorder group 
ranged from 0.81- 1.00 signifying excellent agreement, the Asperger’s Syndrome group 
ranged from 0.93- 1.00 signifying excellent agreement and the PDD-NOS group ranged 
from 0.73-1.00 signifying good to excellent agreement. Excellent agreement was found 
across ASD diagnosis on principal diagnosis (Autistic Disorder: k= 0.93, Asperger’s 
Syndrome: k= 0.85, PDD-NOS: k= 1.00). See Table 5 for inter-rater agreement on 
individual diagnoses using ASD diagnosis as a moderator. 
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DISCUSSION 
The present study examined the inter-rater reliability of the ADIS-IV-C/P in 
youth with ASD. Clinician inter-rater agreement on principal diagnosis (k=0.91) was 
excellent. This indicates that when raters are presented with a number of anxiety 
diagnoses in a youth with ASD, they can reliably agree on the most severe and interfering 
anxiety diagnosis which would become the primary focus of treatment. Notably, Cohen 
kappa for clinician inter-rater agreement on principle diagnosis could be lower if a larger 
number of diagnoses could be chosen to be the principal diagnosis (e.g., all anxiety 
disorders examined by the ADIS-IV). However, as others have reported (e.g., Lyneham 
et al., 2007), discrepancies were noticed in clinician ratings when deciding whether social 
phobia or GAD was the principal diagnosis. One possible explanation is that the overlap 
in the diagnostic criteria of specific anxiety disorders may contribute to inter-rater 
disagreements on the principal diagnosis (Lyneham et al., 2007). For example, clinicians 
may disagree about whether social phobia stands alone as the primary diagnosis or is 
subsumed under GAD in a youth with ASD. Clinician disagreements underscore the 
notion that anxiety in youth with ASD is a dimensional construct that cannot always be 
easily mapped onto a categorical system of classification, as specified by the DSM-IV on 
which the ADIS-IV-C/P is grounded.  
Clinician agreement on the presence of individual anxiety diagnoses (k= 0.85-
0.97) and other comorbid diagnoses (k= 0.89-1.00) was excellent but not perfect. 
Disagreement on the presence of anxiety and comorbid diagnoses among clinicians may 
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arise due to specific clinician, child and ASD variables. These variables will be reviewed 
below. 
Clinician Variables 
Several clinician variables may present challenges to clinician inter-rater 
agreement. First, it is important to note that anxiety in youth with ASD has been 
operationalized through many different measures (e.g., physiological manifestations, 
behavioral observations, number of presented symptoms to meet DSM-IV criteria) 
(Grondhuis & Aman, 2012; Storch et al., 2013; White et al., 2009). Clinicians may also 
vary on how they determine whether or not anxiety symptoms are clinically significant 
despite the categorical approach of the DSM-IV, which has symptoms endorsed as 
present or absent. Clinicians can differ on how they interpret anxiety. Second, clinicians 
have to use their clinical judgment about whether or not the anxiety causes clinically 
significant distress or impairment to meet criteria for a clinical disorder since these terms 
are not specified by the DSM-IV or the ADIS-IV (Beals et al., 2004) which can lead to 
disagreements about the presence or absence of a disorder. Clinical judgment may be 
informed by previous experience of working with youth with anxiety and/or clinical 
training, which inevitably differs among clinicians. As a result, disagreements about 
whether anxiety symptoms meet the threshold to be classified as clinical anxiety may 
arise. Third, when interviewing parents and their children separately, clinicians may vary 
on their beliefs about who is apt to provide more useful information, the parent or the 
child.  For example, a clinician may more readily agree with the parent’s reports of an 
anxiety disorder than the child’s report whereas another clinician may give equal weight 
to parent and child reports. These differences in the evaluation of parent’s and child’s 
18 
 
insight may result in raters’ disagreements about the presence, severity and level of 
interference of an anxiety and/or comorbid disorder. Moreover, whereas others have 
reported that children are better reporters than their parents on internalizing symptoms 
(e.g., Reich, 2000), this does not appear to hold true in youth with ASD (Storch et al.,  
2012a). Lastly, similar conditions seen in youth with ASD are also seen in youth with 
ASD and anxiety (e.g., sleep disturbance, irritability, restlessness, avoidance) (Kim et al., 
2000; Mayes, Calhoun, Murray, Ahuja, & Smith, 2011; Tsai, 1996). Consequently, a 
phenomenon known as “diagnostic overshadowing bias” in which the clinician attributes 
comorbid mental health problems (e.g., anxiety symptoms) to the ASD diagnosis rather 
than a separate clinical disorder may explain differential diagnoses (Mason & Scior, 
2004). Our finding of excellent agreement across anxiety and comorbid diagnoses was 
not significantly impacted by these possible clinician variables. 
Child Variables 
Youth with anxiety and ASD present a number of challenges to diagnostic 
assessments of anxiety. First, although two children can have the same anxiety disorder, 
the presentation of their symptoms can widely vary. For example, two children can be 
diagnosed with GAD but differ substantially on the content (e.g., one child excessively 
worries about his/her performance and impressions while another child is excessively 
concerned about his/ her health and ongoing world events) and the somatic expressions of 
their worries (e.g., irritability versus restlessness). Consequently, clinicians are faced with 
the challenge of deciding which clinical anxiety diagnosis best represents these 
symptoms. Second, youth can have varying levels of insight into their anxiety symptoms 
(Lewin et al., 2010), which makes it difficult for clinicians to formulate a diagnostic 
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evaluation based upon their reports. Lastly, comorbidity is highly prevalent in youth with 
ASD who seek treatment for anxiety (Ung et al., in press; Wood et al., 2009) and may 
complicate diagnostic assessments of anxiety by blurring the lines between what is 
anxiety-driven and what is caused by a comorbid condition. For example, a youth with 
anxiety who acts aggressively towards others and is defiant may be diagnosed as having 
oppositional defiant disorder. However, these behavior problems may stem from the 
child’s anxiety rather than a separate clinical disorder. For example, the child may 
express rage as a way to cope with his/her anxiety or to avoid anxiogenic triggers (Storch 
et al., 2012b). Excellent but not perfect agreement may reflect clinicians’ disagreements 
about the underlying reason for these comorbid conditions. 
ASD Variables 
Characteristics unique to youth with ASD also create challenges to the assessment 
and diagnosis of clinical anxiety and can lead to clinician inter-rater disagreement. First, 
deficits that characterize ASD symptomology (i.e., impairments in social, communication 
and/or cognitive functioning and restricted interests/repetitive behaviors) may restrict the 
youth’s level of insight and ability to reliably convey his/her emotional states. For 
example, a youth with ASD who has difficulty answering questions because he/she is 
preoccupied with his/her restricted interests may not provide reliable and/or valid 
responses which make it difficult for the clinician to come to a conclusive diagnosis 
based upon the child’s report. Moreover, cognitive deficits may lead youth with ASD to 
misinterpret or take phrases or common sayings literally. For example, when asked if 
he/she feels “butterflies in his/her stomach” when encountering anxiety provoking 
situations, a youth with ASD may be confused about what this saying intends to convey 
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and may look confuse and/or respond with a “no”. These core deficits of ASD make it 
difficult for clinicians to accurately assess clinical disorders in youth with ASD and 
anxiety and can lead to poor inter-rater disagreement. Second, youth with ASD struggle 
with the interpretation and communication of their emotions and behaviors and 
understanding the emotions and behaviors of others (Hill, Berthoz, & Firth, 2004). Many 
youth with ASD also show severe impairments of or a lack of the theory of mind 
(Yirmiya et al., 1998). For example, youth with ASD may not fully comprehend what it 
means to be anxious or depressed, despite being given examples of other children who 
may experience these types of emotions, which is a common procedure in the ADIS-IV-
C. Consequently, clinicians may have more difficulties determining the presence or 
absence of a disorder in youth with ASD and these decisions can lead to poorer inter-rater 
agreement. Lastly, overlap in ASD and anxiety symptomology presents a frequent 
challenge to clinicians and parents. Anxiety symptoms may be mistaken for symptoms of 
ASD or vice versa (e.g., obsessive-compulsive symptoms may be mistaken for restricted 
interests or repetitive behaviors) by clinician, parent and child, resulting in differential 
anxiety diagnoses among raters. 
Inter-rater Agreement on Parent and Child Ratings 
Inter-rater agreement on parent and child ratings was excellent suggesting that 
information gathered from parent and child interviews can be reliably captured by two 
separate clinicians. The interview structure of the ADIS-IV-C/P allows for a clear and 
direct report of parent and child ratings of the severity and level of interference of 
individual anxiety and comorbid disorders (e.g., clear cut-off severity score to meet 
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diagnosis). Consequently, raters are more likely to agree that the parent and the child 
reported an individual anxiety or comorbid condition to be clinically significant. 
Moderators of Agreement 
Consistent with previous findings (e.g., Lyneham et al., 2007; Rapee et al., 1994), 
age and ASD diagnosis were not significant moderators of clinician inter-rater agreement. 
Overall, excellent agreement was found across age groups and ASD diagnoses. Inter-rater 
agreement did not vary across ASD diagnoses, indicating that ASD diagnosis does not 
significantly impact rater agreement. As a spectrum disorder, youth with ASD can vary 
on the frequency and severity of ASD symptomology and may not be best categorized as 
belonging to one category versus another. Although not statistically significant, inter-
rater agreement varied more so in the adolescent group (ages 12-16 years) than the child 
group (ages 7-11 years). One possible explanation is that because children may be less 
reliable at reporting their anxiety symptoms, clinicians may rely more heavily on parents’ 
report. In contrast, adolescents may be better reporters of their anxiety, which 
consequently present more information for clinicians to consider. With more information 
available, clinicians may be more likely to differ on what information they use to decide 
the presence or absence of a disorder, resulting in greater inter-rater disagreement. 
Limitations 
 Although excellent inter-rater agreement on principal diagnoses, individual 
anxiety diagnoses, and comorbid DSM-IV diagnoses was found, several limitations 
should be noted. First, due to the use of archival tapes, a second face-to-face ADIS-IV-
C/P interview could not be performed by the second rater to obtain inter-rater reliability. 
Face-to-face interviews may provide clinicians with further details about anxiety 
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symptoms and the reliability of parent and child reports. For example, facial or body cues 
such as expressions of boredom or a need to quickly finish the assessment may inform 
clinicians about the reliability of parent and child reports. Second, given the low sample 
size in some groups, low statistical power may explain why age groups and ASD 
diagnosis were not found to be significant moderators of inter-rater agreement. Third, a 
majority of the sample were Caucasian youth with ASD, limiting the generalizability of 
the results. Lastly, concerns about how the new changes of the DSM-5 in the specific 
area of autism spectrum disorders and anxiety disorders may affect the generalizability of 
this results which are based upon the DSM-IV should be noted. Minor changes to the 
criteria of anxiety disorders within the DSM-5 may not affect the interpretation of the 
results of this study; however, the restructure of the criteria needed to meet an autism 
spectrum diagnosis may exclude a number of youth who had previously been diagnosed 
with ASD, specifically youth with Asperger’s Syndrome and thereby, limiting the 
generalizability and interpretation of our moderation results. 
Clinical Implications 
The present study is the first to indicate the reliable use of the ADIS-IV-C/P in 
youth with ASD. Study results have several clinical implications. First, disagreements 
among clinicians indicate that identifying, assessing and diagnosing clinical anxiety in 
youth with ASD present several unique challenges (e.g., overlap in anxiety and ASD 
symptomology, communication deficits, low levels of insight, difficulty understanding 
and expressing emotions in themselves and others). Clinicians’ awareness of these 
challenges is critical to the success of reliable and valid assessments of anxiety in youth 
with ASD. For example, clinicians who are aware that youth with ASD have difficulty 
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understanding their emotions may rephrase their questions to best fit the cognitive 
abilities of the youth with ASD (e.g., explain anxiety in terms of physical symptoms or 
thoughts rather than using the emotion word “anxiety”). Second, it is impossible to 
develop treatment goals and treatment plans without a reliable case conceptualization of 
the child (Cormier, Nurius, & Osborn, 2009). Inaccurate or incomplete assessment of a 
child’s anxiety symptoms can lead to an inappropriate and ineffective treatment (e.g., 
King et al., 2009). For example, a clinician who mistakes restricted interests and 
repetitive behaviors for OCD symptoms may administer a treatment protocol that is 
inappropriate for the youth or does not follow the recommended treatment. Lastly, 
researchers are increasingly studying anxiety in youth with ASD using the ADIS-IV-C/P, 
and they must be able to reliably assess anxiety in youth with ASD to enroll appropriate 
participants for their studies and to assign treatments that appropriately match each 
child’s clinical characteristics. For example, if a youth with ASD can be reliably 
diagnosed with an anxiety disorder and a comorbid diagnosis such as ADHD, treatment 
targeted at reducing ADHD symptoms prior to or in conjunction with the anxiety 
treatment may maximize treatment efficacy by removing treatment barriers associated 
with comorbid conditions (e.g., increasing attention) (Storch et al., 2008). Consequently, 
understanding the functionality and impairments associated with anxiety and comorbid 
conditions in youth with ASD through reliable assessments and matching patient 
characteristics to certain interventions is critical to the success of individualized 
treatments for youth with ASD and anxiety (e.g., cognitive-behavioral therapy) (Wood & 
Gadow, 2010). 
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Appendix A: Figures 
 
 
Figure 1. Cohen Kappa table for each individual anxiety and comorbid disorder. 
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Appendix B: Tables 
 
Table 1  
 
Inclusion and Exclusion Criteria 
 
 ASD Child Study #1 ASD Child Study #2 ASD Adolescent Study #1 ASD Adolescent Study #2 
Inclusion Criteria ·Ages 7-11 years ·Ages 7-12 years ·Ages 11-16 years ·Ages 11-14 years 
 ·Meets criteria for ASD ·Meets criteria for ASD ·Meets criteria for ASD ·Meets criteria for ASD 
 ·Meets criteria for separation 
anxiety disorder, generalized 
anxiety disorder, social 
phobia, or obsessive-
compulsive disorder according 
to the ADIS-IV-P/C 
·Meets criteria for separation 
anxiety disorder, generalized 
anxiety disorder, social phobia, 
panic disorder or specific 
phobia according to the ADIS-
IV-P/C 
·Meets criteria for separation 
anxiety disorder, generalized 
anxiety disorder, social phobia, 
or obsessive-compulsive 
disorder according to the 
ADIS-IV-P/C 
·Meets criteria for a clinically 
significant anxiety disorder 
as assessed by the ADIS-IV-
P/C 
 ·Has a full scale IQ equal or 
above 70 as assessed by the 
Wechsler Intelligence Scale 
for Children-Fourth Edition or 
a similar standardized test 
·Has a full scale IQ equal or 
above 85 as assessed by the K-
BIT-2 (Kaufman Brief 
Intelligence Test, 2nd edition) 
·Has a full scale IQ equal or 
above 80 as assessed by the 
WISC-IV 
·Has a full scale IQ equal or 
above 85 
 ·Has a minimum score of 14 
on the Pediatric Anxiety 
Rating Scale 
·Has a minimum score of 12 on 
the Pediatric Anxiety Rating 
Scale 
·Has a minimum score of 13 
on the Pediatric Anxiety 
Rating Scale 
 
     
Exclusion 
Criteria  
 
 
 
 
 
 
·Does not meet criteria for 
bipolar disorder, 
schizophrenia or 
schizoaffective disorder 
within the past 6 months 
·Does not meet criteria for 
bipolar disorder, schizophrenia 
or schizoaffective disorder 
within the past 6 months 
·Does not meet criteria for 
bipolar disorder, schizophrenia 
or schizoaffective disorder 
within the past 6 months 
·Does not meet criteria for 
bipolar disorder, 
schizophrenia or 
schizoaffective disorder 
within the past 6 months 
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Table 1 
(continued) 
·Currently receiving 
psychotherapy, social skills 
training or behavioral 
interventions at the same time 
as the cognitive-behavioral 
psychotherapy 
·Currently receiving 
psychotherapy, social skills 
training or behavioral 
interventions at the same time 
as the cognitive-behavioral 
psychotherapy 
·Currently receiving 
psychotherapy, social skills 
training or behavioral 
interventions at the same time 
as the cognitive-behavioral 
psychotherapy 
·Currently receiving 
psychotherapy, social skills 
training or behavioral 
interventions at the same 
time as the cognitive-
behavioral psychotherapy 
 ·Displays clinically significant 
suicidality or engages in 
suicidal behaviors within the 
last 6 months 
·Displays clinically significant 
suicidality or engages in 
suicidal behaviors within the 
last 6 months 
·Displays clinically significant 
suicidality or engages in 
suicidal behaviors within the 
last 6 months 
·Displays clinically 
significant suicidality or 
engages in suicidal behaviors 
within the last 6 months 
 ·Initiates an antidepressant 
within the 12 weeks preceding 
study enrollment or an 
antipsychotic within 8 weeks 
prior to study enrollment, or 
made any changes in 
established psychotropic 
medication (e.g., 
antidepressants, anxioloytics) 
within 8 weeks before study 
enrollment or during 
psychotherapy 
·Initiates an antidepressant 
within the 12 weeks preceding 
study enrollment or an 
antipsychotic within 8 weeks 
prior to study enrollment, or 
made any changes in 
established psychotropic 
medication (e.g., 
antidepressants, anxioloytics) 
within 8 weeks before study 
enrollment or during 
psychotherapy 
·Initiates an antidepressant 
within the 12 weeks preceding 
study enrollment or an 
antipsychotic within 8 weeks 
prior to study enrollment, or 
made any changes in 
established psychotropic 
medication (e.g., 
antidepressants, anxioloytics) 
within 8 weeks before study 
enrollment or during 
psychotherapy 
·Initiates an antidepressant 
within the 12 weeks 
preceding study enrollment 
or an antipsychotic within 6 
weeks prior to study 
enrollment, or made any 
changes in established 
psychotropic medication 
(e.g., antidepressants, 
anxioloytics) or an 
established medication within 
8 weeks before study 
enrollment or during 
psychotherapy 
 ·Parents are unwilling to 
accompany their children for 
multiple study visits 
·Parents are unwilling to 
accompany their children for 
multiple study visits 
·Parents are unwilling to 
accompany their children for 
multiple study visits 
·Parents are unwilling to 
accompany their children for 
multiple study visits 
 ·Has a significant and/or 
unstable medical condition 
that would interfere with 
therapy or needed constant 
medical attention 
·Has a significant and/or 
unstable medical condition that 
would interfere with therapy or 
needed constant medical 
attention 
·Has a significant and/or 
unstable medical condition that 
would interfere with therapy or 
needed constant medical 
attention 
·Has a significant and/or 
unstable medical condition 
that would interfere with 
therapy or needed constant 
medical attention 
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Table 2 
 
  
Demographic and Diagnostic Characteristics of the Sample 
 
    No.         % 
Age, years 
  7-11 years 41 59% 
12-16 years 29 41% 
   Gender 
  Male 59 84% 
Female 11 16% 
   Ethnicity 
  Caucasian  65 93% 
Hispanic 3 5% 
Asian 1 1% 
Other 1 1% 
   Principal Diagnosis 
  Social Phobia 33 47% 
Obsessive-Compulsive Disorder 23 33% 
Generalized Anxiety Disorder 9 13% 
Separation Anxiety Disorder 5 7% 
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Table 3 
 
Demographic and Diagnostic Characteristics of the Sample by ASD Study  
 
 Study 
Sample 
Size 
Age (years) 
(Mean, Standard 
Deviation, Range) Gender (n, %) Ethnicity (n,%) ASD Diagnosis (n, %) 
ACH 21 
Mean= 8.90,  
SD= 1.02, 
range= 7-11 
Males= 17 (81%),  
Females= 4 (19%) 
Caucasian: 18 (86%), 
Hispanic: 2 (10%),  
Asian: 1 (5%),  
Other: 0 (0%) 
AD: 9 (43%), AS: 10 (48%), 
PDD: 2 (9%) 
CCAL 8 
Mean= 8.63,  
SD= 1.65,  
range= 7-11 
Males= 8 (100%),  
Females= 0 (0%) 
 
Caucasian: 8 (100%), 
Hispanic: 0 (0%),  
Asian: 0 (0%),  
Other: 0 (0%) 
AD: 4 (50%), AS: 3 (38%) 
PDD: 1 (12%) 
USF 19 
Mean= 12.05,  
SD= 1.10,  
range= 11-13 
Males= 14 (74%), 
Females= 5 (26%) 
 
Caucasian: 18 (95%), 
Hispanic: 0 (0%),  
Asian: 0 (0%),  
Other: 1 (5%) 
AD: 4 (21%), AS: 10 (53%), 
PDD: 5 (26%) 
AASD 22 
Mean= 12.95,  
SD= 1.40,  
range= 11-16 
Males= 20 (91%), 
Females= 2 (9%) 
 
Caucasian: 21 (95%), 
Hispanic: 1 (5%),  
Asian: 0 (0%),  
Other: 0 (0%) 
AD: 6 (27%), AS: 9 (41%), 
PDD: 7 (32%) 
      Note: AD= Autistic Disorder, AS= Asperger's Syndrome, PDD= Pervasive Developmental Disorders- Not otherwise specified
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Table 4 
 
Kappa Coefficients for Inter-rater agreement on Parent and Child ADIS and Clinician 
 
Diagnoses 
    
  
Inter-rater 
agreement on 
Parent ADIS 
Inter-rater 
agreement on 
Child ADIS 
Inter-rater agreement 
on Clinician 
Diagnoses  
(95% CI) 
Separation Anxiety Disorder 1.00 1.00 0.85 (0.71-0.97) 
Social Phobia 1.00 1.00 1.00 
Specific Phobia 1.00 1.00 0.94 (0.85-1.00) 
Panic Disorder 1.00 1.00 1.00 
Generalized Anxiety Disorder 1.00 1.00 0.96 (0.89-1.00) 
Obsessive-Compulsive Disorder 1.00 1.00 0.97 (0.91-1.00) 
Posttraumatic Stress Disorder 1.00 1.00 1.00 
Depressive Disorders 1.00 1.00 0.89 (0.74-1.00) 
ADHD- Inattentive 1.00 1.00 1.00 
ADHD- Hyperactivity 1.00 1.00 1.00 
ADHD- Combined Type 1.00 1.00 1.00 
Oppositional Defiant Disorder 1.00 1.00 0.97 (0.90-1.00) 
 
*Note: CI= Confidence Interval, Depressive Disorders= Major Depressive Disorder and 
Dysthymia, ADHD= Attention Deficit Hyperactivity Disorder
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Table 5  
      
Kappa Coefficients for Inter-rater Agreement on Clinician  
 
Diagnoses by Age and ASD Diagnosis 
   
      
  
Ages (7-11) 
(n=41) 
Ages (12-16) 
(n=29) 
Autistic Disorder 
(n=23) 
Asperger's Disorder 
(n=32) 
PDD-NOS 
(n=15) 
Separation Anxiety 
Disorder 0.90 (0.76-1.00) 0.73 (0.44-1.00) 0.81 (0.56-1.00) 0.93 (0.79-1.00) 0.73 (0.39-1.00) 
Social Phobia 1.00 N/A 1.00 1.00 N/A 
Specific Phobia 0.94 (0.83-1.00) 0.93 (0.79-1.00) 0.86 (0.60-1.00) 0.94 (0.82-1.00) 1.00 
Panic Disorder 1.00 1.00 N/A 1.00 1.00 
Generalized Anxiety 
Disorder 1.00 0.89 (0.67-1.00) 1.00 1.00 0.87 (0.62-1.00) 
Obsessive-Compulsive 
Disorder 1.00 0.93 (0.79-1.00) 0.91 (0.73-1.00) 1.00 1.00 
Posttraumatic Stress 
Disorder 1.00 1.00 1.00 1.00 N/A 
Depressive Disorders 1.00 0.83 (0.60-1.00) N/A 1.00 1.00 
ADHD- Inattentive 1.00 1.00 1.00 1.00 1.00 
ADHD- Hyperactivity 1.00 1.00 1.00 1.00 N/A 
ADHD- Combined Type 1.00 1.00 1.00 1.00 1.00 
Oppositional Defiant 
Disorder 1.00 0.92 (0.77-1.00) 1.00 0.93 (0.80-1.00) 1.00 
      *Note: CI= Confidence Interval, Depressive Disorders= Major Depressive Disorder and Dysthymia, ADHD= Attention 
Deficit Hyperactivity Disorder, PDD-NOS= Pervasive Developmental Disorders- Not Otherwise Specified, N/A= data 
were not available due to sufficient data to find variability and low base rate 
 
